Contemporary Trends in the Treatment of Mild Ischemic Stroke with Intravenous Thrombolysis: Paul Coverdell National Acute Stroke Program
Open Access
- 17 August 2021
- journal article
- research article
- Published by S. Karger AG in Cerebrovascular Diseases
- Vol. 51 (1) , 60-66
Abstract
Background: Presentation with mild symptoms is a common reason for intravenous thrombolysis (IVT) nonuse among acute ischemic stroke (AIS) patients. We examined the impact of IVT on the outcomes of mild AIS over time. Methods: Using the Paul Coverdell National Stroke Program data, we examined trends in IVT utilization from 2010 to 2019 among AIS patients presenting with National Institutes of Health Stroke Scale (NIHSS) scores ≤5. Outcomes adjudicated included rates of discharge to home and ability to ambulate independently at discharge. We used generalized estimating equation models to examine the effect of IVT on outcomes of AIS patients presenting with mild symptoms and calculated adjusted odds ratio (AOR) with 95% confidence intervals (CI). Results: During the study period, 346,762 patients presented with mild AIS symptoms. Approximately 6.2% were treated with IVT. IVT utilization trends increased from 3.7% in 2010 to 7.7% in 2019 (p < 0.001). Patients treated with IVT had higher median NIHSS scores upon presentation (IVT 3 [2, 4] vs. no IVT 2 [0, 3]). Rates of discharge to home (AOR 2.06, 95% CI: 1.99–2.13) and ability to ambulate at time of discharge (AOR 1.82, 95% CI: 1.76–1.89) were higher among those treated with IVT. Conclusion: There was an increased trend in IVT utilization among AIS patients presenting with mild symptoms. Utilization of IVT increased the odds of being discharged to home and the ability to ambulate at discharge independently in patients with mild stroke.Keywords
This publication has 24 references indexed in Scilit:
- Thrombolysis in Patients With Mild StrokeStroke, 2014
- Review, Historical Context, and Clarifications of the NINDS rt-PA Stroke Trials Exclusion CriteriaStroke, 2013
- Variability in the Use of Intravenous Thrombolysis for Mild Stroke: Experience Across the SPOTRIAS NetworkJournal of Stroke and Cerebrovascular Diseases, 2013
- Racial and Ethnic Disparities in the Use of Intravenous Recombinant Tissue Plasminogen Activator and Outcomes for Acute Ischemic StrokeJournal of Stroke and Cerebrovascular Diseases, 2013
- Discharge Destination as a Surrogate for Modified Rankin Scale Defined Outcomes at 3- and 12-Months Poststroke Among Stroke SurvivorsArchives of Physical Medicine and Rehabilitation, 2012
- Ninety-Day Outcome Rates of a Prospective Cohort of Consecutive Patients With Mild Ischemic StrokeStroke, 2012
- Racial Disparities in Tissue Plasminogen Activator Treatment Rate for StrokeStroke, 2011
- Zero on the NIHSS Does Not Equal the Absence of StrokeAnnals of Emergency Medicine, 2011
- Strokes With Minor SymptomsStroke, 2010
- What Is a Minor Stroke?Stroke, 2010